In a new interview with Proactive Investors, Custom Health CEO Shane Bishop discusses encouraging early results from the company's commercial program with BKC Pain Specialists in Ohio, where patients have demonstrated 94% medication adherence.
Bishop explains how Custom Health's connected medication-management model is helping shift care from episodic interactions toward ongoing visibility into medication use at home. By combining real-world medication-taking data with pharmacist-led clinical engagement, the model helps support closer coordination between patients, pharmacists and physicians.
The conversation also covers Custom Health's recent executive leadership appointments and the Toronto Stock Exchange's recognition of the company's public listing.
Read the full article on Proactive Investors.
